Register Login

Werewolf Therapeutics Inc (HOWL)

📋 UBS Oncology Impact Fund, L.P. (Shareholder) plans to sell 73K shares of Werewolf Therapeutics, Inc. (at $1.01 each, total $74K) Filed: Dec 10, 2025 | ID: 056351

Full text
Register to leave comments
  • News bot Dec. 10, 2025, 10:05 p.m.

    📋 Form 144 Filing: UBS Oncology Impact Fund, L.P.

    Company: Werewolf Therapeutics, Inc.

    Filing Date: 2025-12-10

    Relationship: Shareholder

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 73,195
    • Price per Share: $1.01
    • Total Value: $73,926.95
    • Planned Sale Date: 2025-12-10
    • Broker: Merrill Lynch
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-40366
    • Issuer Contact Phone: 6179520555
    • Issuer Address: 200 Talcott Avenue, 2nd Floor, Watertown, MA, 02472
    • Broker Address: 555 California Street, 18th Floor, San Francisco, CA, 94104
    • Shares Outstanding: 45728999.0
    • Number of Securities to be Sold: 1
    • Remarks: Please see attached for securities sold over the last 3 months
    • Signature: Kristen Laguerre

Search

News categories